BioSpace News Archive

Deals

Gilead Bets $405M on MiroBio’s Checkpoint Agonists for Autoimmune Disease

Gilead snapped up U.K.-based MiroBio in a $405 million deal that will bring its checkpoint agonists and discovery platform under Gilead’s umbrella.

August 5, 2022
·
4 min read
·
Alex Keown
Drug Development

Sometimes, Clinical Trials Miss the Mark: Neurocrine, Akebia, Eliem and Athira

This week, drugs developed by Neurocrine Biosciences, Akebia, Eliem and Athira all failed to meet expectations in clinical trials.

August 5, 2022
·
4 min read
·
Mark Terry
Policy

White House Declares Monkeypox a Public Health Emergency

With more than 6,600 cases of monkeypox in the United States, the Biden administration declared the viral outbreak a public health emergency as cases continue to rise across the nation.

August 5, 2022
·
3 min read
·
Alex Keown
ATP Danger Signal Mechanism could Lead to New Vaccines and Allergy Therapies

A new discovery related to the mechanism of the danger signal adenosine triphosphate could influence how immunomodulators, such as vaccines and allergy medications, are formulated.

August 5, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Drug Development

Clinical Catch-Up: New Monkeypox Trial, Another COVID-19 Antiviral & WCLC

With Monkeypox, COVID-19, Long COVID symptoms and persistent diseases like cancer and Alzheimer’s, the world is dealing with a lot right now. Here’s a look at the latest in clinical trial news.

August 5, 2022
·
4 min read
·
Mark Terry
Business

Global Blood Therapeutics Stock Soars Following Pfizer M&A Rumors (Updated)

Shares of Global Blood Therapeutics are surging once again after reports indicate Pfizer is the mystery suitor for the company. Pfizer could potentially pay as much as $5 billion for the company.

August 5, 2022
·
3 min read
·
Alex Keown
Drug Development

Neuro News: Acadia Receives CRL, Sosei and Microglia Advance Schizophrenia Treatment & More

This week’s highlights in neurological diseases include Acadia receiving a CRL for its ADP drug, Sosei and Neurocrine’s schizophrenia drug study moving on to Phase II.

August 5, 2022
·
3 min read
·
Vanessa Doctor, RN
Lone Star Bio

Top Texas Companies Hiring Now

Known as the Lone Star Bio Hotbed, Texas is home to multiple major players in the biopharma and biotech space and is currently a fast-growing hub for the life science industry.

August 5, 2022
·
2 min read
·
Rosemary Scott
Business

Sanofi Expands China Footprint with Innovent Collaboration

The agreement will grant Innovent exclusive development and marketing rights to tusamitamab in China, while Sanofi will be entitled to up to $81 million in milestones and royalties.

August 5, 2022
·
2 min read
·
Tristan Manalac
Career Advice

What to Do After an Interview to Better Your Odds

You know it’s important to nail the interview with a potential employer, but it’s what you do after an interview that might really influence your chances of getting the job. Find out how in our guide.

August 5, 2022
·
5 min read
·
Kaley Lefevre